Related Experiment Video
Updated: Oct 19, 2025

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
Factors Affecting Prevalence of Urinary Tract Infection in Neonates with Unexplained Hyperbilirubinemia: A Systematic
Fahimeh Bagheri Amiri1, Sanaz Tavasoli1, Nasrin Borumandnia1
1Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Insights
Urinary tract infection (UTI) affects 6.81% of Iranian neonates with unexplained hyperbilirubinemia. Male gender and low birth weight significantly increase UTI risk in this vulnerable population.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Public Health
Background:
- Urinary tract infection (UTI) prevalence and risk factors in neonates with unexplained hyperbilirubinemia require further investigation.
- UTI prevalence varies geographically, necessitating region-specific data.
Purpose of the Study:
- To determine the pooled prevalence of UTI in Iranian neonates presenting with unexplained hyperbilirubinemia.
- To identify risk factors associated with UTI in this specific neonatal population.
Main Methods:
- A meta-analysis was conducted using data from 2000-2018.
- International (Web of Science, PubMed, Scopus, Google Scholar) and national (Science Information Database, Magiran) databases were searched.
- Keywords included "Urinary Tract Infections OR UTI", "urine OR culture OR microbio", "jaundice OR icter OR hyperbili", and "Iran".
Main Results:
- A total of 4210 neonates from 17 studies were analyzed.
- The pooled prevalence of UTI was 6.81% (95% CI: 4.86-8.77).
- Higher UTI prevalence was observed in neonates with prolonged jaundice, low birth weight, and exclusive breastfeeding. Male gender and low birth weight approximately doubled the risk of UTI.
Conclusions:
- A significant prevalence of UTI exists in neonates with unexplained hyperbilirubinemia.
- Given the identified risk factors, screening for UTI is crucial in the workup of these neonates.
Background:
The prevalence and risk factors of urinary tract infection (UTI) in neonates with unexplained hyperbilirubinemia are not studied thoroughly. Since the prevalence of UTI is highly variable in different areas and countries, this study aimed to review the existing data of Iranian neonates with UTI presented with unexplained hyperbilirubinemia.
Methods:
This study is a meta-analysis of Iranian newborns with unexplained hyperbilirubinemia. We identified all studies indexed in international (Web of Science, PubMed, Scopus, Google Scholar) and national (Science Information Database, Magiran) databases from 2000-2018. Search terms included: Urinary Tract Infections OR UTI AND urine OR culture OR microbio, jaundice OR icter OR hyperbili, AND Iran.
Results:
Overall, 4210 neonates from 17 studies were included. The pooled prevalence of UTI in neonates with unexplained hyperbilirubinemia was 6.81% (95% CI: 4.86-8.77). Considering the subgroups analyses; the prevalence of UTI was higher in the prolonged vs. not-prolonged state (8.34% vs. 4.00%), low birth weight vs. normal birth weight (7.81% vs. 4.51%), and exclusive vs. non-exclusive breastfeeding (8.84% vs. 4.72%). Male gender and low birth weight increased the risk of UTI about two times compared to the female gender and normal birth weight, respectively. The results of the analyses in neonates with unconjugated hyperbilirubinemia also showed the above-mentioned subgroup differences.
Conclusion:
Due to considerable prevalence of UTI in neonates with unexplained hyperbilirubinemia and risk factors in this age group, investigation for UTI is essential for the workup in this situation.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Pharmacokinetics in Pediatric Patients: Drug Distribution
Urinary Tract Infection I: Introduction

